Dallas-based buyout house Pharos Capital has sold its stake in infectious disease and parasite diagnostic test maker TechLab. The post Pharos exits six-year investment in infectious disease testing specialist TechLab first appeared on AltAssets Private
Private equity investment major Ardian has bought a majority stake in bio-analytical lab testing services business GBA Group.
Stockholm's Summa Equity has bought a majority stake in protein production and research specialist Sengenics through its €610m second fund.
Capricorn Venture Partners has made the second investment from its Digital Growth Fund by backing the €38m Series B round for medical device business Indigo Diabetes.
Carlyle has reportedly made a 7x return selling digital test automation and monitoring software business Eggplant to trade buyer Keysight.
